Integral Health Asset Management’s Biogen BIIB Stock Holding History

Integral Health Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.6M	Buy	100,000 +40,000	+67%	+$7.65M	0.85%	32
2026 Q1	$11M	Sell	60,000 -40,000	-40%	-$7.37M	0.53%	50
2025 Q4	$17.6M	Buy	+100,000	New	+$16.3M	0.87%	40
2023 Q2	–	Sell	-40,000	Closed	-$11.1M	–	80
2023 Q1	$11.1M	Buy	+40,000	New	+$11.1M	2.24%	13
2022 Q4	–	Sell	-50,000	Closed	-$13.3M	–	68
2022 Q3	$13.3M	Buy	+50,000	New	+$10.6M	2.59%	14
2022 Q2	–	Sell	-15,000	Closed	-$3.16M	–	69
2022 Q1	$3.16M	Sell	15,000 -20,000	-57%	-$4.35M	0.82%	43
2021 Q4	$8.4M	Buy	+35,000	New	+$9M	2.32%	13
2021 Q3	–	Sell	-35,000	Closed	-$12.1M	–	78
2021 Q2	$12.1M	Buy	+35,000	New	+$10.6M	3.34%	6
2021 Q1	–	Sell	-10,000	Closed	-$2.45M	–	74
2020 Q4	$2.45M	Buy	+10,000	New	+$2.58M	0.73%	42

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Integral Health Asset Management's BIIB Position: Q2 2026 in Review

Integral Health Asset Management increased its Biogen (BIIB) stake by 67% in Q2 2026, buying an estimated $7.65M and bringing the position to 100,000 shares worth $21.6M. The position accounts for 0.85% of the portfolio, ranked #32.

Integral Health Asset Management first reported a position in BIIB in Q4 2020 and has held it in 9 quarters since. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Integral Health Asset Management held 100,000 shares of Biogen worth $21.6M as of Q2 2026.
Integral Health Asset Management bought 40,000 Biogen shares in Q2 2026, an estimated $7.65M.
Biogen made up 0.85% of Integral Health Asset Management's portfolio in Q2 2026, its #32 holding.
Integral Health Asset Management first reported a position in Biogen in Q4 2020 and has held it in 9 quarters since.
1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.